middle.news
Biotron appoints Penthrox veteran to steer SedRx and antiviral programs
9:50am on Wednesday 14th of October, 2026 AEDT
•
Healthcare and biotechnology
Read Story
Biotron appoints Penthrox veteran to steer SedRx and antiviral programs
9:50am on Wednesday 14th of October, 2026 AEDT
Key Points
Glenn Gilbert starts as CEO and executive director on 18 January 2027
$250,000 annual salary plus statutory superannuation
Up to 100 million unlisted options priced at $0.0041
Up to $230,000 in milestone-based cash bonuses
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Biotron (ASX:BIT)
OPEN ARTICLE